Caffeine challenge test and panic disorder: a systematic literature review

References

• James JE. Understanding Caffeine: A Biobehavioral Analysis. Behavioral Medicine and Health Psychology Series (Volume 2). Sage Publications, CA, USA, 159–219 (1997).
   Google Scholar
• McEvoy GK, Miller J, Litvak K. In: American Hospital Formulary Service – Drug Information 2005. American Society of Health-System Pharmacists. MD, USA, 2368 (2005).
   Google Scholar
• Pacheco AHR, Araujo DMR, Lacerda EMA et al. [Caffeine consumption by pregnant women selected from a Health Care Center in the municipality of Rio de Janeiro, Brazil]. Rev. Bras. Ginecol. Obstet.30(5), 232–240 (2008).
   PubMedGoogle Scholar
• Tassaneeyakul W, Birkett DJ, McManus ME et al. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Biochem. Pharmacol.47, 1767–1776 (1994).
   PubMed Web of Science ®Google Scholar
• Fenster L, Quale C, Hiatt R et al. Rate of caffeine metabolism and risk of spontaneous abortion. Am. J. Epidemiol.147, 503–510 (1998).
   PubMed Web of Science ®Google Scholar
• Svenningsson P, Nomikos GG, Ongini E, Fredholm BB. Antagonism of adenosine A2A receptors underlies the behavioral activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience79, 753–764 (1997).
   PubMed Web of Science ®Google Scholar
• Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. Structure and function of adenosine receptors and their genes. Arch. Pharmacol.362, 364–377 (2000).
   Google Scholar
• Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr.46(2), 101–123 (2006).
   PubMed Web of Science ®Google Scholar
• Fredholm B, Bättig K, Holmén J et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev.51(1), 83–133 (1999).
   PubMed Web of Science ®Google Scholar
• Sinclair CJD, Geiger JD. Caffeine use in sport: a pharmacological review. J. Sports Med. Phys. Fitness40(1), 71–79 (2000).
   PubMed Web of Science ®Google Scholar
• Souza RAG, Sichieri R. [Caffeine intake and prematurity]. Rev. Nutr.18(5), 643–650 (2005).
   Google Scholar
• Gardinali PR, Zhao X. Trace determination of caffeine in surface water samples by liquid chromatography – atmospheric pressure chemical ionization – mass spectrometry (LC–APCI–MS). Environ. Int.28(6), 521–528 (2002).
   PubMed Web of Science ®Google Scholar
• James JE. Caffeine and Health. Academic Press, London, UK, 432 (1991).
   Google Scholar
• Barone JJ, Roberts H. Human consumption of caffeine. In: Caffeine: Perspectives from Recent Research. Dews PB (Ed.). Springer-Verlag, Berlin, Germany, 59–73 (1984).
   Google Scholar
• Bunker ML, McWilliams M. Caffeine content of common beverages. J. Am. Diet. Assoc.74(1), 28–32 (1979).
   PubMed Web of Science ®Google Scholar
• Graham DM. Caffeine – its identity, dietary sources, intake and biological effects. Nutr. Rev.36(4), 97–102 (1978).
   PubMed Web of Science ®Google Scholar
• Lovett R. Coffee: the demon drink? New Scientist24, 2518–2522 (2005).
   Google Scholar
• Strain EC, Griffiths RR. Caffeine related disorders. In: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry (7th Edition). Sadock BJ, Sadock VA (Eds). Lippincott, MD, USA, 982–990 (2000).
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders – DSM-IV (4th Edition). American Psychiatric Press, DC, USA (1994).
   Google Scholar
• Camargo MCR, Toledo MCF. [Caffeine content of commercial brazilian coffee]. Ciênc. Tecnol. Aliment.18(4), 421–424 (1998).
   Google Scholar
• Charney DS, Heninger GR, Jatlow PI. Increased anxiogenic effects of caffeine in panic disorders. Arch. Gen. Psychiatry42, 233–243 (1985).
   PubMed Web of Science ®Google Scholar
• Greden JF. Anxiety or caffeinism: a diagnostic dilemma. Am. J. Psychiatry131, 1089–1092 (1974).
   PubMed Web of Science ®Google Scholar
• Gilliland K, Andress D. Ad lib caffeine consumption, symptoms of caffeinism, and academic performance. Am. J. Psychiatry138, 512–514 (1981).
   PubMed Web of Science ®Google Scholar
• Hughes JR, Oliveto AH, Helzer JE et al. Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10? Am. J. Psychiatry149, 33–40 (1992).
   PubMed Web of Science ®Google Scholar
• Strain EC, Mumford GK, Silverman K, Griffiths RR. Caffeine dependence syndrome: evidence from case histories and experimental evaluation. JAMA272, 1043–1048 (1994).
   PubMed Web of Science ®Google Scholar
• Ogawa N, Ueki H. Clinical importance of caffeine dependence and abuse. Psychiatry Clin. Neurosci.61, 263–268 (2007).
   PubMed Web of Science ®Google Scholar
• Faravelli C, Paionni A. Panic disorder: clinical course, morbidity and comorbidity. In: Anxiety Disorders: an Introduction to Clinical Management and Research. Griez EJL, Faravelli C, Nutt D, Zohar J (Eds). John Wiley & Sons, NY, USA, 53–79 (2001).
   Google Scholar
• Ballenger JC. Practical approaches to the treatment of panic disorder. J. Clin. Psychiatry57, 45–48 (1996).
   PubMedGoogle Scholar
• McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J. Psychiatr. Res. DOI: 10.1016/j.jpsychires.2011.03.006 (2011) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the national comorbidity survey replication. Arch. Gen. Psychiatry63, 415–424 (2006).
   PubMed Web of Science ®Google Scholar
• Stoney CM, Davis MC, Matthews KA. Sex differences in physiological response to stress and in coronary heart disease: a causal link? Psychophysiology24, 127–131 (1987).
   PubMed Web of Science ®Google Scholar
• Pennebaker JW, Roberts T. Toward a his and hers theory of emotion: gender differences in visceral perception. J. Soc. Clin. Psychol.11, 199–212 (1992).
   Web of Science ®Google Scholar
• Schmidt NB, Koselka M. Gender differences in patients with panic disorder: evaluating cognitive mediation of phobic avoidance. Cognit. Ther. Res.24(5), 533–550 (2000).
   Web of Science ®Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. American Psychiatric Press, DC, USA (1998).
   Google Scholar
• Mellman TA, Udhe TW. Electroencephalographic sleep in panic disorder. Arch. Gen. Psychiatry46, 178–184 (1989).
   PubMed Web of Science ®Google Scholar
• Klein DF, Gorman JM. A model of panic and agoraphobia development. Acta Psychiatr. Scand.76, 87–95 (1987).
   Web of Science ®Google Scholar
• Klein DF, Klein HM. The status of panic disorder. Curr. Opin. Psychiatry1, 177–183 (1988).
   Google Scholar
• Andrews G, Slade T. Agoraphobia without a history of panic disorder may be part of the panic disorder syndrome. J. Nerv. Ment. Dis.190, 624–630 (2002).
   PubMed Web of Science ®Google Scholar
• Goisman RM, Warshaw MJ, Steketee GS et al. DSM-IV and the disappearance of agoraphobia without a history of panic disorder: new data on a controversial diagnosis. Am. J. Psychiatr.152, 1438–1443 (1995).
   PubMed Web of Science ®Google Scholar
• Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry63(4), 415–424 (2006).
   PubMed Web of Science ®Google Scholar
• Lecrubier Y. The impact of comorbidity on the treatment of panic disorder. J. Clin. Psychiatr.59(Suppl. 8), 11–14 (1998).
   PubMed Web of Science ®Google Scholar
• Nardi AE, Valença AM. [Panic disorder: diagnosis and treatment]. In: [Cognitive–Behavioral Psychotherapy]. Ventura P (Ed.). Guanabara Koogan, Rio de Janeiro, Brazil, 90–98 (2005).
   Google Scholar
• Nardi AE, Valença AM. [Panic disorder: diagnosis and treatment]. In: [Treatment with SSRIs Antidepressants]. Lopes FL, Nardi AE (Eds.). Guanabara Koogan, Rio de Janeiro, Brazil, 117–125 (2005).
   Google Scholar
• Nardi AE, Lopes FL, Freire RC et al. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res.169, 149–153 (2009).
   PubMed Web of Science ®Google Scholar
• Masdrakis VG, Papakostas YG, Vaidakis N et al. Caffeine challenge in patients with panic disorder: baseline differences between those who panic and those who do not. Depress. Anxiety25, E72–E79 (2008).
   Web of Science ®Google Scholar
• Graeff FG, Zangrossi H. Animal models of anxiety disorders. In: Textbook of Biological Psychiatry. D’Haenen H, Den Boer JA, Westenberg H, Willner P (Eds). John Wiley & Sons, London, UK, 879–893 (2002).
   Google Scholar
• Graeff FG. Human experimental anxiety. Rev. Psiq. Clín.34(5), 251–253 (2007).
   Google Scholar
• Rehfeld JF, Neilson FC. Molecular form and regional distribution of cholecystokinin in the central and peripheral nervous system. In: Cholecystokinin and Anxiety: From Neuron to Behaviour. Bradwejn J, Vasar E (Eds.). Springer-Verlag, NY, USA, 33–56 (1995).
   Google Scholar
• van Megen HJ, Westenberg HG, den Boer JA, Kahn RS. Cholecystokinin in anxiety. Eur. Neuropsychopharmacol.6, 263–280 (1996).
   PubMed Web of Science ®Google Scholar
• Beinfeld MC, Meyer DK, Eskay RL, Jensen RT, Brownstein MJ. The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res.212, 51–57 (1981).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF. Neuronal cholecystokinin: one or multiple transmitters? J. Neurochem.44, 1–10 (1985).
   PubMed Web of Science ®Google Scholar
• Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch. Gen. Psychiatry50, 306–317 (1993).
   PubMed Web of Science ®Google Scholar
• Zandbergen J, Strahm M, Pols H, Griez EJL. Breath-holding in panic disorder. Compr. Psychiatry33, 47–51 (1992).
   PubMed Web of Science ®Google Scholar
• Nardi AE, Valença AM, Nascimento I et al. A caffeine challenge test in panic disorder patients, their healthy first-degree relatives and healthy controls. Depress. Anxiety25, 847–853 (2008).
   PubMed Web of Science ®Google Scholar
• Klein E, Zohar J, Geraci MF et al. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine’s anxiogenis effects. Biol. Psychiatry30, 973–984 (1991).
   PubMed Web of Science ®Google Scholar
• Araujo DMR, Pereira NL, Kac G. Anxiety during pregnancy, prematurity, and low birth weight: a systematic literature review. Cad. Saúde Pública23, 747–756 (2007).
   PubMed Web of Science ®Google Scholar
• Nardi AE, Lopes FL, Valença AM et al. Caffeine challenge test in panic disorder and depression with panic attacks. Compr. Psychiatry48, 257–263 (2007).
   PubMed Web of Science ®Google Scholar
• Nardi AE, Valença AM, Lopes FL et al. Caffeine and 35% carbon dioxide challenge tests in panic disorder. Hum. Psychopharmacol. Clin. Exp.22, 231–240 (2007).
   PubMed Web of Science ®Google Scholar
• Uhde TW, Boulenger JP. Caffeine model of panic. In: New Directions in Affective Disorders. Lerer B, Gershon S (Eds.), Springer-Verlag, NY, USA, 410–413 (1989).
   Google Scholar
• Uhde TW. Caffeine provocation of panic: a focus on biological mechanisms. In: Neurobiological Aspects of Panic Disorder. Balleger JC (Ed.). Alan Liss, NY, USA, 219–242 (1990).
   Google Scholar
• Shear MK, Greeno C, Kang J et al. Diagnosis of nonpsychotic patients in community clinics. Am. J. Psychiatry157, 581–587 (2000).
   PubMed Web of Science ®Google Scholar
• Steiner Jl, Tebes JK, Sledge WH et al. A comparison of the structured clinical interview for DSM-III-R and clinical diagnoses. J. Nerv. Ment. Dis.183(6), 365–369 (1995).
   PubMed Web of Science ®Google Scholar
• Beck JG, Berisford MA. The effects of caffeine on panic patients: response components of anxiety. Behav. Ther.23, 405–422 (1992).
   Web of Science ®Google Scholar
• Bruce M, Scott N, Shine P, Lader M. Anxiogenic effects of caffeine in patients with anxiety disorders. Arch. Gen. Psychiatry49, 867–869 (1992).
   PubMed Web of Science ®Google Scholar
• Masdrakis VG, Markianos M, Vaidakis N, Papakostas YG, Oulis P. Caffeine challenge and breath-holding duration in patients with panic disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry33, 41–44 (2009).
   PubMed Web of Science ®Google Scholar
• Graeff FG. Minor tranquilizers and brain defense systems. Braz. J. Med. Biol. Res.14, 239–265 (1981).
   PubMed Web of Science ®Google Scholar
• Nashold BS, Wilson WP, Slaughter DG. Sensations evoked by stimulation of the midbrain of man. J. Neurosurg.30, 14–24 (1969).
   PubMed Web of Science ®Google Scholar
• Jenck F, Moreau JL, Martin JR. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Res.57, 181–191 (1995).
   PubMed Web of Science ®Google Scholar
• Alsene K, Deckert J, Sand P, de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology28, 1694–1702 (2003).
   PubMed Web of Science ®Google Scholar
• Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella ILG. The effects of low doses of caffeine on human performance and mood. Psychopharmacology92, 308–312 (1987).
   PubMed Web of Science ®Google Scholar
• Svensson E, Persson LO, Sjoberg L. Mood effects of diazepam and caffeine. Psychopharmacology67, 73–80 (1980).
   PubMed Web of Science ®Google Scholar
• Loke WH. Effects of caffeine on mood and memory. Physiol. Behav.44, 367–372 (1988).
   PubMed Web of Science ®Google Scholar
• Liguori A, Grass JA, Hughes JR. Subjective effects of caffeine among introverts and extraverts in the morning and evening. Exp. Clin. Psychopharmacol.7, 244–249 (1999).
   PubMed Web of Science ®Google Scholar
• van Dam RM, Feskens EJ. Coffee consumption and risk of Type 2 diabetes mellitus. Lancet360, 1477–1478 (2002).
   PubMed Web of Science ®Google Scholar
• Kawachi I, Willett WC, Colditz GA et al. A prospective study of coffee drinking and suicide in women. Arch. Intern. Med.156, 521–525 (1996).
   PubMed Web of Science ®Google Scholar
• Ross GW, Abbott RD, Petrovitch H et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA283, 2674–2679 (2000).
   PubMed Web of Science ®Google Scholar
• Katzung BG. Basic and Clinical Pharmacology (9th Edition). Lange Medical Books, NY, USA, 325–327 (2003).
   Google Scholar
• Heninger GR. A biologic perspective on comorbidity of major depressive disorder and panic disorder. In: Comorbidity of Mood and Anxiety Disorders. Maser J, Cloninger CR (Eds). American Psychiatric Press, Washington, DC, USA, 381–401 (1990).
   Google Scholar
• Broderick P, Benjamin AB. Caffeine and psychiatric symptoms: a review. J. Okla State Med. Assoc.97(12), 538–542 (2004).
   PubMedGoogle Scholar
• Ferré S, Jensen MB, Kempf K et al. What do you see as the main priorities, opportunities, and challenges in caffeine research in the next five years? J. Caffeine Res.1(1), 5–12 (2011).
   Google Scholar